Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-14

FDA Approved: LACOSAMIDE — Original Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approves XLCare Pharmaceuticals' original ANDA for lacosamide, making a generic lacosamide available in the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)